Candidemia on presentation to the hospital: development and validation of a risk score

@inproceedings{Shorr2009CandidemiaOP,
  title={Candidemia on presentation to the hospital: development and validation of a risk score},
  author={Andrew F. Shorr and Ying P. Tabak and Richard S. Johannes and Xiaowu Sun and James Robert Spalding and Marin H Kollef},
  booktitle={Critical care},
  year={2009}
}
INTRODUCTION Candidemia results in substantial morbidity and mortality, especially if initial antifungal therapy is delayed or is inappropriate; however, candidemia is difficult to diagnose because of its nonspecific presentation. METHODS To develop a risk score for identifying hospitalized patients with candidemia, we performed a retrospective analysis of a large database of 176 acute-care hospitals in the United States. We studied 64,019 patients with bloodstream infection (BSI) on… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 37 references

Current status of fungal cell wall components in the immunodiagnostics of invasive fungal infections in humans: galactomannan, mannan and (1-->3)-beta-D-glucan antigens

  • A Kdzierska, P Kochan, A Pietrzyk, J Kdzierska
  • Eur J Clin Microbiol Infect Dis
  • 2007
1 Excerpt

dzierska J : Current status of fungal cell wall components in the immunodiagnostics of invasive fungal infections in humans : galactomannan , mannan and ( 1 -> 3 )betaDglucan antigens

  • P Kochan, A Pietrzyk
  • Eur J Clin Microbiol Infect Dis
  • 2007

Similar Papers

Loading similar papers…